Background Neuraminidase inhibitors were widely used during the 2009–10 influenza A
H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We …

Emerging and re-emerging viral diseases are of great public health concern. The recent
emergence of Severe Acute Respiratory Syndrome (SARS) related coronavirus (SARS-CoV …

Background The burden of H1N1 among socially disadvantaged populations is unclear. We
aimed to synthesize hospitalization, severe illness, and mortality data associated with …

OBJECTIVES: To identify the clinical characteristics of outpatients with flu-like illnesses
stratified by influenza A H1N1 status. METHODS: The study was conducted at the H1N1 staff …

Background Previous reviews found that the H1N1 pandemic was associated with a large
proportion of hospitalizations, severe illness, workplace absenteeism, and high costs …

Background and purpose: Influenza A (H1N1), an acute respiratory disorders, is a highly
contagious virus and can spread from person to person through sneezing or coughing. In …

To study genetic evolution of Moroccan influenza A (H1N1) pdm09 virus strains, we
conducted a molecular characterization of the hemagglutinin gene subunit 1 (HA1) of 36 …

Background. Immediately after the outbreak of novel influenza A (H1N1) in the United States
of America and Mexico, World Health Organization declared a global pandemic (pH1N1). A …

Background and purpose: Influenza A (H1N1), an acute respiratory disorders, is a highly
contagious virus and can spread from person to person through sneezing or coughing. In …

Background: The impact of HIV infection on the incidence and severity of influenza illness in
adults in sub-Saharan Africa (SSA) is unclear. Although annual seasonal influenza …